Neuhaus P - Search Results

1

Complete reversal of acute rejection episodes after syngeneic retransplantation is associated with a TH1/TH2 shift.

Tullius SG, Graser E, Nieminen M, Reutzel-Selke A, Jonas S, Bechstein WO, Volk HD, Neuhaus P. Tullius SG, et al. Among authors: neuhaus p. Transplant Proc. 1999 Feb-Mar;31(1-2):340-1. doi: 10.1016/s0041-1345(98)01653-4. Transplant Proc. 1999. PMID: 10083134 No abstract available.

2

Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation.

Langrehr JM, Schneller A, Guckelberger O, Lohmann R, Neumann U, Jonas S, Klupp J, Settmacher U, Knoop M, Bechstein WO, Neuhaus PJ. Langrehr JM, et al. Among authors: neuhaus pj. Transplant Proc. 1998 Jun;30(4):1439-40. doi: 10.1016/s0041-1345(98)00306-6. Transplant Proc. 1998. PMID: 9636583 No abstract available.

3

Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.

Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Lange D, et al. Among authors: neuhaus p. Transplant Proc. 1993 Apr;25(2):1870-1. Transplant Proc. 1993. PMID: 8470207 Clinical Trial. No abstract available.

4

Imprint cytology in liver transplantation: diagnosis of rejection.

Topalidis T, Blumhardt G, Bechstein WO, Neuhaus P. Topalidis T, et al. Among authors: neuhaus p. Transplant Proc. 1993 Apr;25(2):1978. Transplant Proc. 1993. PMID: 8470250 No abstract available.

5

New preparation method for bile cytology in liver transplantation: diagnosis of rejection.

Topalidis T, Bechstein WO, Böhmann C, Stöckmann K, Neuhaus P. Topalidis T, et al. Among authors: neuhaus p. Transplant Proc. 1993 Apr;25(2):1979. Transplant Proc. 1993. PMID: 8470251 No abstract available.

6

Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.

Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Jonas S, et al. Among authors: neuhaus p. Clin Transplant. 1995 Oct;9(5):406-14. Clin Transplant. 1995. PMID: 8541635 Clinical Trial.

7

Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.

Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H. Bechstein WO, et al. Among authors: neuhaus p. Transplant Proc. 1996 Apr;28(2):1008-10. Transplant Proc. 1996. PMID: 8623211 Clinical Trial. No abstract available.

8

Indications for tacrolimus anti-rejection therapy in liver allograft recipients.

Jonas S, Bechstein WO, Tullius SG, Steinmüller T, Gamm T, Neuhaus P. Jonas S, et al. Among authors: neuhaus p. Transpl Int. 1996;9 Suppl 1:S164-70. doi: 10.1007/978-3-662-00818-8_41. Transpl Int. 1996. PMID: 8959817

9

BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.

Mueller AR, Platz KP, Steinmüller T, Nüssler N, Neumann U, Gerlach H, Stoll C, Bechstein WO, Neuhaus P. Mueller AR, et al. Among authors: neuhaus p. Transplant Proc. 1996 Dec;28(6):3103-5. Transplant Proc. 1996. PMID: 8962203 No abstract available.

10

Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.

Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P. Platz KP, et al. Among authors: neuhaus p, neuhaus r. Transplant Proc. 1996 Dec;28(6):3183-4. Transplant Proc. 1996. PMID: 8962235 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,341 results

Search Page

Filters